Pharmacological activation of plasma-membrane KATP channels reduces reoxygenation-induced Ca(2+) overload in cardiac myocytes via modulation of the diastolic membrane potential

Br J Pharmacol. 2004 Mar;141(6):1059-67. doi: 10.1038/sj.bjp.0705702. Epub 2004 Mar 1.

Abstract

1. The opening of cardiac plasma-membrane ATP-sensitive K(+) channels (pmK(ATP)) can protect the heart against ischaemia/reperfusion injury. We recently demonstrated that the resting membrane potential (E(m)) of ventricular myocytes strongly modulates reoxygenation-induced Ca(2+) overload. This led to the hypothesis that activation of pmK(ATP) can influence the extent of chemically induced hypoxia (CIH)/reoxygenation Ca(2+) overload via hyperpolarization of the diastolic membrane potential of ventricular myocytes. 2. The membrane potential (E(m)) of isolated rat myocytes was determined using the perforated patch-clamp technique and DiBac(4)(3) imaging. Intracellular Ca(2+) ([Ca(2+)](i)) was monitored using FURA-2 imaging. 3. CIH/reoxygenation caused a significant depolarization of E(m) and a substantial increase in [Ca(2+)](i). The K(ATP) opener pinacidil (100 microm) and the pmK(ATP) opener P-1075 (100 microm) hyperpolarized the E(m) of normoxic myocytes. Pinacidil (100 microm) and P-1075 (10 and 100 microm), applied during reoxygenation, hyperpolarized E(m) and prevented reoxygenation-induced increases in [Ca(2+)](i). 4. Myocyte hypercontracture and death increased in parallel with an E(m) depolarization of 10-15 mV and increases in [Ca(2+)](i). Under these conditions, the selective pmK(ATP) channel inhibitor HMR 1098 further depolarized myocyte membrane potential and increased hypercontracture. 5. In conclusion, activation of pmK(ATP) channels can prevent CIH/reoxygenation-induced Ca(2+) overload via a mechanism that is dependent on hyperpolarization of diastolic membrane potential. Hyperpolarization toward normal resting membrane potential favours the Ca(2+) extrusion mode of Na(+)/Ca(2+) exchange.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Barbiturates
  • Benzamides / pharmacology
  • Calcium / metabolism*
  • Cell Hypoxia
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Electric Stimulation
  • Fluorescent Dyes
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels
  • In Vitro Techniques
  • Isoxazoles
  • Membrane Potentials / drug effects
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Patch-Clamp Techniques
  • Pinacidil / pharmacology
  • Poloxamer / pharmacology
  • Potassium Channels, Inwardly Rectifying / antagonists & inhibitors
  • Potassium Channels, Inwardly Rectifying / metabolism*
  • Probenecid / pharmacology
  • Rats

Substances

  • Barbiturates
  • Benzamides
  • Fluorescent Dyes
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels
  • Isoxazoles
  • KCNJ5 protein, human
  • Potassium Channels, Inwardly Rectifying
  • Poloxamer
  • bis(1,3-dibutylbarbiturate)trimethine oxonol
  • Pinacidil
  • HMR 1098
  • Probenecid
  • Calcium